NCT04404660 2025-09-09A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)Autolus LimitedPhase 1/2 Active not recruiting153 enrolled 1 FDA